The correlations of lipid mediators with measures of cognition and AD pathology were stronger in APOE4 carriers compared to APOE3, underscoring the influence of APOE genotype on the extent of neuroinflammation and disease severity. The gene discussed is APOE; the disease is Alzheimer disease.